Trethera to attend RESI Boston 2017

September 7, 2017 – Trethera, a biotechnology company developing innovative small molecule inhibitors of cancer nucleotide metabolism, will be attending RESI Boston 2017 on September 26, 2017.

For more information on Trethera’s attendance, please contact nbajpayee@trethera.com.